市場調查報告書
商品編碼
1354328
柳葉刀市場規模- 按類型(安全柳葉刀、標準柳葉刀、手動啟動柳葉刀、自動啟動柳葉刀)、按尺寸(22G 及以下、23G-33G、33G 以上)、依最終用途- 全球預測(2023-2032)Lancet Market Size - By Type (Safety Lancets, Standard Lancets, Manually Activated Lancets, Automatically Activated Lancets), By Size (22G and Below, 23G-33G, Above 33G), By End-use - Global Forecast (2023-2032) |
在全球糖尿病盛行率不斷上升的推動下,2023 年至 2032 年全球《柳葉刀》市場規模將呈現 4.7% 的複合年成長率。據世界衛生組織稱,糖尿病影響全球約 4.22 億人,其中大多數居住在低收入和中等收入國家。每年,糖尿病直接導致 150 萬人死亡。
隨著越來越多的人需要定期監測血糖,對獲取血液樣本至關重要的採血針的需求將會增加。糖尿病管理中對自我保健和早期疾病管理的重視進一步推動了刺血針市場的發展,因為患者尋求方便有效的工具來監測自己的病情,從而創造了市場擴張的機會。
整個刺血針市場根據類型、尺寸、最終用途和地區進行分類。
2023 年至 2032 年間,安全採血針產業的複合年成長率可能為 5.2%。由於對醫護人員安全和感染控制的擔憂日益增加,對安全採血針的需求正在成長。這些創新設備提供了一種更安全、更衛生的血液採集方式,降低了針刺傷害和交叉污染的風險。因此,醫療機構和專業人員擴大採用安全刺血針來增強工作場所安全和病患照護。
診所可能會成為刺血針的主要最終用戶,由於診斷目的對高效、精確的血液採樣的需求的推動,到 2032 年,該細分市場的規模將以 4.6% 的複合年成長率擴大。採血針提供了一種快速且相對無痛的方法來獲取用於各種醫學測試的血液樣本。由於診所為不同的患者群體提供服務,刺血針的可靠性和易用性使其成為醫療保健專業人員的必備工具,滿足了他們在臨床環境中的高需求。
由於該地區人口老化、糖尿病等慢性病盛行率增加以及對醫療品質和病人安全的高度重視,歐洲刺血針產業正在大幅成長。根據歐盟統計局數據,2022年,歐盟老年扶養比為33%,較前一年上升0.5個百分點,呈現持續上升趨勢。自2012年以來的十年間,這項指標從當年的27.1%上升了5.9個百分點。這些因素推動了對血糖監測和診斷至關重要的刺血針的需求,促進了該行業在歐洲的強勁擴張。
Global Lancet Market size will exhibit 4.7% CAGR from 2023 to 2032, driven by the growing prevalence of diabetes worldwide. According to WHO, diabetes affects approximately 422 million individuals globally, with the majority residing in low- and middle-income nations. Each year, diabetes directly contributes to 1.5 million fatalities.
As more individuals require regular blood glucose monitoring, lancets, crucial for obtaining blood samples, will witness increased demand. The emphasis on self-care and early disease management in diabetes management further propels the lancet market, as patients seek convenient and efficient tools for monitoring their condition, creating opportunities for market expansion.
The overall lancet market is categorized based on type, size, end-use, and region.
The safety lancets industry could demonstrate 5.2% CAGR between 2023 and 2032. The demand for safety lancets is gaining momentum due to growing concerns for healthcare worker safety and infection control. These innovative devices offer a safer and more hygienic way to obtain blood samples, reducing the risk of needlestick injuries and cross-contamination. Consequently, healthcare facilities and professionals are increasingly adopting safety lancets to enhance workplace safety and patient care.
Clinics could emerge as a prominent end-user for lancets, with the segment size expanding at 4.6% CAGR through 2032, driven by the need for efficient and precise blood sampling for diagnostic purposes. Lancets provide a quick and relatively painless way to obtain blood samples for various medical tests. With clinics serving a diverse patient population, the reliability and ease of use of lancets make them essential tools for healthcare professionals, contributing to their high demand in clinical settings.
Europe lancet industry is witnessing substantial growth due to the region's aging population, increased prevalence of chronic diseases like diabetes, and a strong emphasis on healthcare quality and patient safety. According to Eurostat, in 2022, the old-age dependency ratio in the EU stood at 33%, showing a 0.5 percentage point rise from the previous year and indicating a consistent upward trend. Over the decade since 2012, this indicator has increased by 5.9 percentage points, starting from 27.1% in that year. These factors drive the demand for lancets, essential for blood glucose monitoring and diagnostics, contributing to the industry's robust expansion in Europe.